Evaluating Midline Catheters in Clinical Practice

NCT07677696 | Recruiting

• 1 other identifier: Branden-MRW2023
• Study Type: observational
• Target: 10,000
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this observational study is to learn about the safety and effectiveness of midline catheters in patients who receive midline catheter placement as part of their routine clinical care. The main question it aims to answer is: Do midline catheters demonstrate acceptable safety and effectiveness when used in routine clinical practice? Participants who receive a midline catheter as part of their regular medical care will have their clinical data collected from electronic medical records and patient questionnaires, and followed for outcomes related to catheter-related complications and functional performance.

Conditions

Safety and Effectiveness of Midline Catheters; Vascular Access Devices

Keywords

Midline catheters, vascular access devices, catheter-related complications, patient safety, real-world study

Outcome Measures

Primary Outcomes (1)

• Number of Participants With Catheter-Related Complications

  Catheter-related complications include phlebitis, catheter-related bloodstream infection (CRBSI), venous thrombosis, and catheter occlusion. Complication rate is calculated as the number of participants experiencing at least one complication divided by the total number of enrolled participants, multiplied by 100 percent.

  From catheter insertion until removal, assessed up to 28 days

Secondary Outcomes (6)

• Catheter Function Rate

  At catheter removal, assessed up to 28 days

• One-Time Insertion Success Rate

  At catheter insertion, assessed up to 28 days

• Catheter Dwell Time

  From catheter insertion to removal, assessed up to 28 days

• Unplanned Removal Rate

  From catheter insertion to removal, assessed up to 28 days

• Insertion and Maintenance Cost

  From catheter insertion to removal, assessed up to 28 days

Interventions

Midline catheter placement DEVICE

Patients receive a midline catheter as part of their routine clinical care for intravenous therapy lasting 1 to 4 weeks

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients aged 18 years or older receiving a first-time midline catheter as part of their routine clinical care for intravenous therapy expected to last 1 to 4 weeks.

You may qualify if:

• Age ≥ 18 years
• First-time midline catheter placement per physician order
• Not enrolled in another clinical study
• Willing and able to provide informed consent and comply with follow-up (unless consent waived by local ethics committee)

You may not qualify if:

• Deemed unsuitable by investigator (e.g., poor compliance or inability to communicate clearly)
• Refusal of informed consent by patient or family member

Sponsors & Collaborators

• Shandong Branden Med.Device Co.,Ltd: lead
• Zibo Central Hospital: collaborator

Study Sites (1)

Zibo Central Hospital

Zibo, China

RECRUITING

Central Study Contacts

Lina Zhang

CONTACT

+86-18678187002; 1173565974@qq.com

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: PROSPECTIVE
• Target Duration: 28 Days
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: June 13, 2026
• First Posted: July 1, 2026
• Study Start: May 1, 2026
• Primary Completion (Estimated): May 1, 2027
• Study Completion (Estimated): May 1, 2027
• Last Updated: July 1, 2026

Record last verified: 2026-06

Locations

CN (1)